
PD Dr. med.
Regina Schläger
Position(s)
Senior Physician Neurology
Institution
University Hospital Basel
Phone
+41 61 328 67 49
Research Group Regina Schläger
Research Focus
Neurology
Area of Research
Development of quantitative MR and electrophysiological markers for the characterization of neurodegenerative diseases (motor neuron diseases, progressive MS)
Approved Research Projects
2017 - Spinal Cord Imaging in Post Polio Syndrome. Sub-study to the Citrulline Study (EKNZ 2015-221).
2018 - Spinal cord gray matter imaging in Amyotrophic Lateral Sclerosis (EKNZ:2018-0032).
2019 - Spinal cord gray matter imaging - a novel biomarker for Spinal Muscular Atrophy (EKNZ 2019-01228).
2020 - Quantitative Spinal Cord Gray and White Matter Imaging in Amyotrophic Lateral Sclerosis – a post mortem validation study (2020-02179)
2022 - Quantitative Spinal Cord Gray Matter lmaging - a Novel Biomarker for Post-Polio Syndrome, a 5 year follow-up study (2022-01502)
Collaborations
National Collaborations
- Prof. Oliver Bieri, Department of Biomedical Engineering, University of Basel
- Prof. Philippe Cattin, Department of Biomedical Engineering, University of Basel
- Prof. Marco Düring, MIAC AG, Basel
- Prof. Dirk Fischer, UKBB, Basel
- Prof. Cristina Granziera, ThINK, Department of Biomedical Engineering
- Prof. Jens Kuhle, Department of Biomedicine, University of Basel
- Prof. Eva Scheuer, PD Dr. Claudia Lenz, Institut für Rechtsmedizin, Basel
- PD Dr. Mark Sollberger, Memory Clinic, Basel
- Prof. Markus Weber, Kantonsspital St.Gallen, Muskelzentrum/ALS Clinic
International Collaborations
- Prof. Roland Henry, UCSF, San Francisco, USA
- PD Thorsten Langer, Universitätskinderklinik, Freiburg i. B.
Ongoing Research Projects
Spinal cord gray matter imaging in ALS (EKNZ:2018-0032). Active recruiting.
Quantitative Spinal Cord Gray and White Matter Imaging in Amyotrophic Lateral Sclerosis – a post mortem validation study (2020-02179). Active recruiting.
Quantitative Spinal Cord Gray Matter lmaging - a Novel Biomarker for Post-Polio Syndrome, a 5 year follow-up study (2022-01502). Not yet recruiting.
Spinal cord gray matter imaging - a novel biomarker for Spinal Muscular Atrophy. (EKNZ 2019-01228). Completed.
Brainstem Atrophy in Multiple Sclerosis and Neurodegenerative diseases. Substudy to the Gene-MSA Study (EKNZ 285/11).